Bladder Cancer Trial, Recruiting NCT05792033 Sponsor: Medical University of Vienna Condition: Bladder Cancer
Back to Bladder Cancer

Bladder Cancer Trial, Recruiting

NCT05792033
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with a specific early-stage bladder cancer (called primary T1 bladder cancer), confirmed by lab results from tissue samples.
  • Your diagnosis has been confirmed by a second surgical procedure to check the bladder (called a second-look TURB).
  • Scans and imaging show that the cancer has not spread to your lymph nodes or other parts of your body.
  • You agree to have surgery and are willing to follow the recommended follow-up care and treatment after surgery, as set out in current medical guidelines.
  • If cancer was still found at your second check procedure, it can only be included if a specific deeper layer of bladder tissue (called detrusor muscle) was present in the sample taken (confirm with trial site).

Who may not be able to join:

  • You have had bladder cancer before.
  • The second check procedure showed the cancer has grown deeper into the bladder wall (becoming what is called muscle-invasive bladder cancer).
  • You have a medical reason that makes surgery unsafe or not possible (for example, scarring of the bladder called bladder fibrosis).
  • Your overall health is too poor to safely undergo surgery.
  • Your life expectancy is less than one year.
  • You do not wish to take part in the trial.
  • You are pregnant.
  • You have been diagnosed with, or previously had, a type of cancer affecting the urinary tract above the bladder (called upper urinary tract urothelial cancer).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +434040026150

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 June 2021
Est. completion
31 December 2023

Where this trial is recruiting

🇦🇹 Austria

Primary endpoints

Therapy failure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov